Karydas Daphne — SEC insider filings

SEC reporting owner CIK 1816952. 17 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2020-12-14 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mineralys Therapeutics, Inc. (MLYS)Director8—5 legs · 24,000 sh · $925,53713
COMPASS Pathways plc (CMPS)Director4——4
LogicBio Therapeutics, Inc. (LOGC)Director4——4
Syndax Pharmaceuticals Inc (SNDX)Chief Financial Officer1——1

Insider filings — Karydas Daphne

FiledFormIssuerReported transactionsSource
2026-09-174Mineralys Therapeutics, Inc. (MLYS)Option exercise (M): 3,000 @ $12.02 · Sale (S): 3,000 @ $28.58 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2026-06-174Mineralys Therapeutics, Inc. (MLYS)Option exercise (M): 3,000 @ $12.02 · Sale (S): 3,000 @ $25 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2026-05-294COMPASS Pathways plc (CMPS)Grant/award (A): 21,110 (derivative) @ $0EDGAR
2026-04-024Mineralys Therapeutics, Inc. (MLYS)Option exercise (M): 3,000 @ $12.02 · Sale (S): 3,000 @ $25 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2026-02-204Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0EDGAR
2025-11-134Mineralys Therapeutics, Inc. (MLYS)Option exercise (M): 15,000 @ $10.20 · Sale (S): 10,115 @ $45.81 · Sale (S): 4,885 @ $46.36 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-06-134COMPASS Pathways plc (CMPS)Grant/award (A): 26,000 (derivative) @ $0EDGAR
2025-02-244Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 32,900 (derivative) @ $0EDGAR
2024-05-234Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2024-05-134COMPASS Pathways plc (CMPS)Grant/award (A): 26,000 (derivative) @ $0EDGAR
2023-09-204COMPASS Pathways plc (CMPS)Grant/award (A): 52,000 (derivative) @ $0EDGAR
2023-09-144Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 44,000 (derivative) @ $0EDGAR
2022-11-174LogicBio Therapeutics, Inc. (LOGC)Disposition to issuer (D): 12,500 (derivative)EDGAR
2022-07-054LogicBio Therapeutics, Inc. (LOGC)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2021-06-144LogicBio Therapeutics, Inc. (LOGC)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2021-02-054Syndax Pharmaceuticals Inc (SNDX)Grant/award (A): 95,000 (derivative) @ $0EDGAR
2020-12-144LogicBio Therapeutics, Inc. (LOGC)Grant/award (A): 20,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816952 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs